Totally three articles regarding associations of Nurr1 gene mutations, LRRK2 gene polymorphism sites S1647T and R1398H, and polymorphism of PARK2 gene mutations with Han Chinese patients with Parkinson\'s disease were published in *Neural Regeneration Research*. We hope that our readers find these papers useful to their research.

**Abstract**

Nurr1 defects could in part underlie Parkinson\'s disease (PD) pathogenesis, and Nurr1 gene polymorphism has been found in Caucasian patients with PD. In this study, heteroduplex technology was applied to compare the DNA sequences of eight exons of Nurr1 among 200 sporadic PD patients and 200 healthy controls in the Han population in the Hubei province, China. One allele amplified from exon 3 of Nurr1 was polymorphic in five PD patients (2.5%, 5/200), and two individuals had a polymorphic allele amplified from exon 2 (1%, 2/200). The anomalous electrophoresis fragment in exon 3 of Nurr1 gene contained a 709C/A missense mutation, and a polymorphic single nucleotide polymorphism at 388G/A was identified in exon 2. Compared with the control group, the Nurr1 gene expression level in the PD group was decreased, and the Nurr1 gene expression levels in PD patients carrying the polymorphisms at exons 2 and 3 were significantly decreased. Our data indicate that the single nucleotide polymorphism 388G/A in exon 2 and the 709C/A missense mutation in exon 3 of the Nurr1 gene in the Chinese population might affect the pathogenesis of PD.
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**Abstract**

A recent multicenter study demonstrated that two variants of LRRK2, S1647T and R1398H, are associated with sporadic Parkinson\'s disease (PD). The present study analyzed LRRK2 gene polymorphisms of S1647T and R1398H, demonstrating that the LRRK2 gene polymorphism S1647T variant is a risk factor for PD in a Chinese Han population. However, the R1398H variant did not influence the risk for PD. In addition, there was no difference in clinical symptoms of PD patients with various genotypes. Results showed that the LRRK2 S1647T variant was associated with an increased risk for developing early-onset PD in a Chinese Han population. In addition, there was no correlation between LRRK2 S1647T, R1398H variants and G2385R, R1628P variants in PD patients.
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**Abstract**

The parkin gene (PARK2) is a common disease gene in Han Chinese patients with Parkinson\'s disease (PD). The detection of mutations in the PARK2 gene remains low. To investigate the role PARK2 gene mutations play in the pathogenesis of PD, 30 Han Chinese patients with early-onset PD and 38 normal controls were studied to determine the sequence changes of 1, 4, 6 and 7 exon sections. In the 30 patients with PD, a heterozygous intron mutation (nt 119, G→G/A) in exon 1 was detected in one case; a homozygous intron mutation (nt 526500, T→C) between intron 3 and exon 4 in fourteen cases was found; a heterozygous intron mutation (nt 526607, G→G/A) between intron 3 and exon 4 was observed in eight cases; an exon 6 missense mutation (nt 754317, C→C/T; codon 193, CGG→CGG/TGG; aa 193, Arg→Arg/Trp) in three cases was seen; and an exon 7 missense mutation (nt 941943, C→A/C; codon 272, CTC→CTC/ATC; aa 272, Leu→Leu/Ile) was found in one case. These changes were not found in the normal population. The results indicated that the PARK2 exons 6 and 7 mutations are possibly pathogenic mutations, along with the intron 3-exon 4 and exon 1 mutations. PARK2 gene mutations are possible factors leading to the onset of PD.
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